Scientists in laboratory examining plant extracts for pharmaceutical research and botanical medicine development

Thailand University Partners Taiwan Firm on Plant Medicine

🤯 Mind Blown

A leading Thai university is teaming up with a Taiwanese biotech company to advance plant-based medicine and bring clinical-tested beauty products to Southeast Asia. The partnership puts Thailand at the forefront of botanical pharmaceutical innovation.

Thailand just took a major step forward in plant-based medicine innovation, and it could change how Southeast Asia approaches natural healthcare products.

Mahidol University's Faculty of Pharmacy signed a five-year research agreement with Taiwan's WE-WIN BIO-MEDICAL this week, bringing together decades of botanical science expertise from both countries. The partnership was announced at one of Asia's largest cosmetic and beauty exhibitions in Bangkok.

The collaboration goes beyond research papers. WE-WIN and Mahidol's pharmaceutical production facility will manufacture the APERDU hair revitalizing product locally in Thailand, making it one of the few cosmetic products in the country backed by clinical trials and pharmaceutical-grade manufacturing standards.

"Most cosmetics are never tested the way high quality products are," said James Hsieh, WE-WIN's CEO. "APERDU was studied in an IRB-approved human clinical trial in Taiwan, and now, produced here in Thailand under professional pharmaceutical production facility, that level of science is available directly to Thai consumers."

The partnership covers joint research projects, professional training, academic visits, and sharing scientific knowledge about naturally derived bioactive ingredients. These plant-based compounds could have applications across both pharmaceutical and cosmetic science.

Thailand University Partners Taiwan Firm on Plant Medicine

WE-WIN brings US-patented green extraction technology and more than 35 international patents to the table. The company sources botanical ingredients from endemic plant species worldwide, including rare Japanese cherry blossom extracts and marine ingredients from Hokkaido's waters.

The Ripple Effect

This partnership positions Thailand as a regional hub for botanical pharmaceutical innovation. The collaboration gives Thai researchers access to cutting-edge extraction technologies while providing WE-WIN with manufacturing capabilities and market access across Southeast Asia.

The agreement also strengthens scientific ties between Taiwan and Thailand, creating opportunities for student exchanges and professional development. Young researchers from both countries will gain hands-on experience translating laboratory discoveries into real products that reach consumers.

For Thai consumers, the partnership means access to rigorously tested natural health and beauty products manufactured locally under pharmaceutical standards. It's a model that could raise quality benchmarks across the entire regional cosmetics industry.

Associate Professor Surakit Nathisuwan, Dean of Mahidol's Faculty of Pharmacy, emphasized the practical impact. "This collaboration reflects our Faculty's commitment to research partnerships that translate scientific expertise into real outcomes for Thailand and the wider region."

At the Bangkok exhibition, WE-WIN introduced eight new botanical active ingredients for the pharmaceutical and cosmetic industries, showcasing the kind of innovation this partnership aims to accelerate.

Thailand's blend of biodiversity, scientific expertise, and manufacturing capability is creating new possibilities for plant-based medicine worldwide.

More Images

Thailand University Partners Taiwan Firm on Plant Medicine - Image 2
Thailand University Partners Taiwan Firm on Plant Medicine - Image 3
Thailand University Partners Taiwan Firm on Plant Medicine - Image 4

Based on reporting by Regional: thailand innovation (TH)

This story was written by BrightWire based on verified news reports.

Spread the positivity!

Share this good news with someone who needs it

More Good News